
Colgate-Palmolive (CL) Stock Forecast & Price Target
Colgate-Palmolive (CL) Analyst Ratings
Bulls say
Colgate-Palmolive is a leading player in the household and personal care industry with a strong international presence and diversified product portfolio. While the company has faced challenges in the North American market, it has seen success in other regions through its dual-brand therapeutic strategy. With a focus on new innovations and cost savings, along with a commitment to diversity and inclusion, Colgate-Palmolive is expected to regain market share and continue its positive growth trajectory.
Bears say
Colgate-Palmolive is facing significant challenges in the North American market. Their self-inflicted pricing issues and under-investment in marketing have led to negative sales and loss of market share to competitors like P&G and Haleon. These issues can be addressed through disruptive innovation and the deployment of a dedicated premium therapeutic brand, as seen in their successful European strategy. However, without these changes, the company may struggle to stabilize in this market. Additionally, Colgate-Palmolive has potential upside in their pet food business and cost-saving initiatives, but their downside scenario valuation is lower than the current stock price.
This aggregate rating is based on analysts' research of Colgate-Palmolive and is not a guaranteed prediction by Public.com or investment advice.
Colgate-Palmolive (CL) Analyst Forecast & Price Prediction
Start investing in Colgate-Palmolive (CL)
Order type
Buy in
Order amount
Est. shares
0 shares